Last reviewed · How we verify
NCT06945133: AMIVAL
Correlation Study Between the Classification of Arthrogenic Motor Inhibition (AMI) and Clinical Assessment After ACL Rupture
NA trial testing Clinical testing in ACL - Anterior Cruciate Ligament Rupture in 90 participants. Not yet recruiting.
31 December 2026
Quick facts
| Lead sponsor | GCS Ramsay Santé pour l'Enseignement et la Recherche |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 90 |
| Start date | 1 December 2025 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across France |
Drugs / interventions tested
- Clinical testing
Conditions studied
- ACL - Anterior Cruciate Ligament Rupture — all drugs for ACL - Anterior Cruciate Ligament Rupture →
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche — full company profile →
Who can join
Adults 18 to 44, any sex, with ACL - Anterior Cruciate Ligament Rupture. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this interventional study is to measure medial vastus inhibition and associate it with AMI classification in patients with ACL rupture. The main question it aims to answer is: Is there a correlation between AMI classification and clinical assessment after ACL rupture ? Participants will undergo surface EMG and Myotonometry.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06945133
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for ACL - Anterior Cruciate Ligament Rupture
Currently open trials in the same condition.
- NCT07030764 — Comparison of Arthrogenic Muscle Inhibition (AMI) After ACL Reconstruction in Patients With Conventional Rehabilitation · NA · recruiting
- NCT06973785 — Non-Narcotic Pain Control After ACL Reconstruction · Phase 3 · recruiting
- NCT07043569 — Clinical-randomized Trial of the Effect of Rehabilitation Therapy Using Strength and Blood Flow Restriction Training on · NA · recruiting
- NCT07009392 — Microbiological Molecular Profile of the Knee Joint During Primary Reconstruction or Revision Surgery of the ACL · NA · active not recruiting
- NCT06235736 — Do Patients With ACL Tears Demonstrate Weakness of the Soleus Muscle? · recruiting
Other GCS Ramsay Santé pour l'Enseignement et la Recherche trials
Trials by the same sponsor.
- NCT07274657 — Superb Microvascular Imaging (SMI) and Two-Dimensional Endoscopic Ultrasound Guided Shear Wave Elastography (2D-SWE-EUS) · NA · not yet recruiting
- NCT07271277 — 3D MRI Assessment of Femoroacetabular Impingement in Patients With ACL Rupture - Exploratory Study · NA · not yet recruiting
- NCT07263997 — Assessment of a New Traction Device in Submucosal Dissection of Colorectal Lesions · NA · not yet recruiting
- NCT07249645 — Description of Return to Sport in Amateur Athletes Who Underwent Several Functional Tests (K-STARTS, Vertical Jumps and · NA · not yet recruiting
- NCT06678646 — Ultrasound-guided Release of the Median Nerve at the Elbow in Patients With Lacertus Syndrome · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06945133 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by GCS Ramsay Santé pour l'Enseignement et la Recherche
- Last refreshed: 19 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06945133.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing